Silexion Therapeutics Corp - 8-K Filing

Silexion Therapeutics Corp increased authorized share capital by 10 million shares to support warrant exercisability and other corporate actions. (Items: 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, 5.07 below, 9.01 Financial Statements and Exhibits)

SEC EDGAR ·

Tickers: $SLXN

Read the full article at SEC EDGAR

More Regulatory news